Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1993-12-02
1996-01-02
Lovering, Richard D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546 67, 546 69, A61K 3144
Patent
active
054808855
ABSTRACT:
A method of treating psychosis including administering an antipsychotically effective amount of an ergolinyl derivative of 2-propinylamine of the formula I ##STR1## wherein, R.sub.1, R.sub.2, and R.sub.3 independently represent a hydrogen atom or a straight-chain or branched-chain C.sub.1 -C.sub.6 alkyl group, X represents a hydrogen or a halogen atom, Z represents a carbonyl or methylene group, and C.sub.9 - - - -C.sub.10 represents a single or a double, diastereomeric forms, racemates and acid addition salts thereof.
REFERENCES:
patent: 3228944 (1966-01-01), Bernardi
patent: 3346580 (1967-10-01), Hofmann et al.
patent: 4064249 (1977-12-01), Mago
Bole-Vunduk Breda
Krisch Igor
Lavric Bogomila
Ocvirk Magdalena
Rucman Rudolf
Kilby Scalzo Catherine S.
Lek, Tovarna Farmacevtskih in Kemicnih
Lovering Richard D.
LandOfFree
Ergoline derivatives of 1-propinylamine, a process for the manuf does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Ergoline derivatives of 1-propinylamine, a process for the manuf, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ergoline derivatives of 1-propinylamine, a process for the manuf will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-235339